- This event has passed.
CSL Behring Research Acceleration Initiative Lunch and Learn
February 10 @ 12:00 pm - 1:00 pm
At this event, which includes lunch, participants can learn more about the new CSL – Science Center Research Acceleration Initiative, which will provide funding of as much as $400,000 over the next two years to fund novel technologies in CSL Behring’s focused therapeutic areas.
CSL Behring is a leading global biotechnology company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives. CSL has partnered with the University City Science Center, a nonprofit institution that has been dedicated to identifying and nurturing promising technology for over half a century, to build the CSL – Science Center Research Acceleration Initiative.
The initiative will fund up to three proposals in 2020 and provide access to industry resources. Successful applicants will receive up to $200,000 per year for up to two years (maximum $400,000 funding) to accelerate translation of their research.
The initiative seeks innovations from CSL Therapeutic’s key topics, which have an emphasis on rare disease and include immunology, neurology, hematology, thrombosis, transplant, respiratory and cardiovascular/metabolic.
Focus areas include novel drug targets, novel therapeutic candidates and novel strategies for treating disease.
Relevant modalities include antibodies, protein therapeutics, gene therapies and cell therapies; small molecules are not of interest.
Applications will be accepted through April 9, 2020.